You may find more results for this query on our sister sites: GenomeWeb and Precision Oncology News.
NEW YORK — Centogene said on Monday that it has signed an agreement to provide diagnostic testing services for aromatic L-amino acid decarboxylase (AADC) deficiency to PTC Therapeutics, which is developing a treatment for the rare disease.
...and receive Daily News bulletins.
Already have a 360Dx or GenomeWeb account?Login Now.
Don't have a 360Dx or GenomeWeb account?Register for Free.